Literature DB >> 16473369

Elongated oligomers assemble into mammalian PrP amyloid fibrils.

M Howard Tattum1, Sara Cohen-Krausz, Kanjana Thumanu, Christopher W Wharton, Azadeh Khalili-Shirazi, Graham S Jackson, Elena V Orlova, John Collinge, Anthony R Clarke, Helen R Saibil.   

Abstract

In prion diseases, the mammalian prion protein PrP is converted from a monomeric, mainly alpha-helical state into beta-rich amyloid fibrils. To examine the structure of the misfolded state, amyloid fibrils were grown from a beta form of recombinant mouse PrP (residues 91-231). The beta-PrP precursors assembled slowly into amyloid fibrils with an overall helical twist. The fibrils exhibit immunological reactivity similar to that of ex vivo PrP Sc. Using electron microscopy and image processing, we obtained three-dimensional density maps of two forms of PrP fibrils with slightly different twists. They reveal two intertwined protofilaments with a subunit repeat of approximately 60 A. The repeating unit along each protofilament can be accounted for by elongated oligomers of PrP, suggesting a hierarchical assembly mechanism for the fibrils. The structure reveals flexible crossbridges between the two protofilaments, and subunit contacts along the protofilaments that are likely to reflect specific features of the PrP sequence, in addition to the generic, cross-beta amyloid fold.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16473369     DOI: 10.1016/j.jmb.2006.01.052

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  25 in total

1.  Natural and synthetic prion structure from X-ray fiber diffraction.

Authors:  Holger Wille; Wen Bian; Michele McDonald; Amy Kendall; David W Colby; Lillian Bloch; Julian Ollesch; Alexander L Borovinskiy; Fred E Cohen; Stanley B Prusiner; Gerald Stubbs
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-28       Impact factor: 11.205

2.  Comparison of Alzheimer Abeta(1-40) and Abeta(1-42) amyloid fibrils reveals similar protofilament structures.

Authors:  Matthias Schmidt; Carsten Sachse; Walter Richter; Chen Xu; Marcus Fändrich; Nikolaus Grigorieff
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-20       Impact factor: 11.205

3.  Structural dependence of HET-s amyloid fibril infectivity assessed by cryoelectron microscopy.

Authors:  Naoko Mizuno; Ulrich Baxa; Alasdair C Steven
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

Review 4.  The diversity and relationship of prion protein self-replicating states.

Authors:  Nina Klimova; Natallia Makarava; Ilia V Baskakov
Journal:  Virus Res       Date:  2014-10-13       Impact factor: 3.303

5.  Disulfide mapping reveals the domain swapping as the crucial process of the structural conversion of prion protein.

Authors:  Iva Hafner-Bratkovič; Roman Jerala
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

Review 6.  Folding versus aggregation: polypeptide conformations on competing pathways.

Authors:  Thomas R Jahn; Sheena E Radford
Journal:  Arch Biochem Biophys       Date:  2007-06-08       Impact factor: 4.013

7.  Left handed beta helix models for mammalian prion fibrils.

Authors:  Kay C Kunes; Scott C Clark; Daniel L Cox; Rajiv R P Singh
Journal:  Prion       Date:  2008-04-23       Impact factor: 3.931

8.  Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.

Authors:  Nathan J Cobb; Frank D Sönnichsen; Hassane McHaourab; Witold K Surewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

9.  Probing structural differences in prion protein isoforms by tyrosine nitration.

Authors:  Christopher W Lennon; Holly D Cox; Scott P Hennelly; Sam J Chelmo; Michele A McGuirl
Journal:  Biochemistry       Date:  2007-03-31       Impact factor: 3.162

10.  Globular tetramers of beta(2)-microglobulin assemble into elaborate amyloid fibrils.

Authors:  Helen E White; Julie L Hodgkinson; Thomas R Jahn; Sara Cohen-Krausz; Walraj S Gosal; Shirley Müller; Elena V Orlova; Sheena E Radford; Helen R Saibil
Journal:  J Mol Biol       Date:  2009-04-05       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.